We statistically analyzed the relationships between recurrence risk, BRAF gene mutation, gender, age at first thyroid cancer diagnosis, tumor size, extrathyroidal invasion, lymph node metastasis, and distant metastasis as well as the expression levels of PROS1, CLU, and LRG1. This evidence concerns the gene CLU and thyroid gland carcinoma.